Evidence map›Paper›PMID 41383827›Full record

ArticleNAR genomics and bioinformatics2025

RNA-binding proteins connect Exon usage to the chromatin.

Hanah Robertson, Hoang T T Do, Volkhard Helms

Abstract read
In one paragraph

Article in NAR genomics and bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hanah RobertsonCenter for Bioinformatics, Saarland University, 66041 Saarbrücken, Germany.
Hoang T T DoCenter for Bioinformatics, Saarland University, 66041 Saarbrücken, Germany.
Volkhard HelmsCenter for Bioinformatics, Saarland University, 66041 Saarbrücken, Germany.ORCID https://orcid.org/0000-0002-2180-9154

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exonic enrichment of histone marks hints at their role in regulating alternative splicing. This study aims to connect the transcriptome and epigenome in the context of splicing outcomes in embryonic cell lines. The tools rMATS and MANorm were used to obtain estimates of differential inclusion of exons and differential enrichment of epigenetic signals, respectively. Two classes of alternative exons were identified in embryonic cell lines: those differentially co-occurring with at least one mark among H3K27ac, H3K27me3, H3K36me3, H3K9me3, and H3K4me3, and those marked by neither of these marks. Binary classifiers were trained using RNA-binding protein (RBP) binding affinities on the flanking regions of these exons. This resulted in a set of RBPs, whose putative binding was predicted to associate local chromatin modification marking an exon with its differential inclusion, some of which have been experimentally shown to interact with histone mark reader proteins. We speculate that sequence signals harbored at exon-intron flanks regulate differential splicing of exons, marked by at least one of the five epigenetic signatures. Finally, eCLIP data from ENCODE for the HepG2 and K562 cell lines support TIA1 and U2AF2 as potential episplicing RBPs, as predicted by our model in the embryonic cell lines.

Indexed as

Alternative SplicingChromatinExonsRNA-Binding ProteinsEpigenesis, GeneticHep G2 CellsHistonesHumansK562 CellsSplicing Factor U2AFChromatinHistonesRNA-Binding ProteinsSplicing Factor U2AFU2AF2 protein, human

Identifiers

PMID41383827
PMCPMC12693533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.